US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

ATYR PHARMA INC

0.3892

+0.00060.15%

Pre-market: 0.3810-0.0082-2.11%08:05 EDT

Volume:1.06M

Turnover:408.97K

Market Cap:38.14M

PE:-0.63

High:0.4008

Open:0.3940

Low:0.3750

Close:0.3886

52wk High:1.20

52wk Low:0.3750

Shares:97.99M

Float Shares:95.97M

Volume Ratio:0.96

T/O Rate:1.10%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-0.6214

EPS(LYR):-0.7971

ROE:-98.68%

ROA:-46.58%

PB:0.78

PE(LYR):-0.49

Loading ...

Overview Company News Filings

aTyr Pharma Announces Special Shareholder Meeting

aTyr Pharma Expects FDA Response by Mid-September on Efzofitimod Phase 3 Sarcoidosis Protocol

aTyr Pharma Provides Update on Timing of Regulatory Response for Planned Phase 3 Study of Efzofitimod in Pulmonary Sarcoidosis

THOMSON REUTERS

aTyr Pharma Announces Special Shareholder Meeting

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Embecta Corporation (EMBC) and aTyr Pharma (ATYR)

ATyr Pharma to Cut 60% of Staff, Bring in New CFO in Restructuring Push

aTyr Pharma Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

aTyr Pharma Q2 Net Loss Narrows

aTyr Pharma Submits Phase 3 Efzofitimod Trial Protocol to FDA for Pulmonary Sarcoidosis Study

aTyr Pharma Q2 EPS $(0.11) Beats $(0.12) Estimate

Benzinga Earnings

aTyr Pharma - Expects $13 Mln Reduction in Annualized Operating Expenses Beginning Q4 2026

THOMSON REUTERS

aTyr Pharma - Announces Workforce Reduction of About 60% to Focus on Efzofitimod Program

THOMSON REUTERS

aTyr Pharma - Jill Broadfoot to Step Down as CFO; Brandon Yaras Appointed CFO Effective October 1, 2026

THOMSON REUTERS

Press Release: aTyr Pharma Announces Second Quarter 2026 Results, Program Prioritization and Corporate Restructuring to Support Efzofitimod Program in ILD

Ethos Technologies Q2 Revenue Rises 113% on Policy Growth

aTyr Pharma Q2 Net Income USD 19.531 Million

THOMSON REUTERS

aTyr Pharma Inc Expected to Post a Loss of 12 Cents a Share - Earnings Preview

aTyr Pharma - Co and Kyorin Terminate Collaboration Agreement Effective July 30, 2026 - SEC Filing

THOMSON REUTERS

aTyr Pharma - Regains Exclusive Global Rights to Efzofitimod - SEC Filing

THOMSON REUTERS

aTyr Pharma Lawsuit: Company Asks Court to Dismiss Investor Securities Claims

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.imtigers.com/stock/ATYR/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"ATYR","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ATYR\",,,,,undefined,":{"symbol":"ATYR","market":"US","secType":"STK","nameCN":"ATYR PHARMA INC","latestPrice":0.3892,"timestamp":1789502400000,"preClose":0.3886,"halted":0,"volume":1059982,"hourTrading":{"tag":"盘前","latestPrice":0.381,"preClose":0.3892,"latestTime":"08:05 EDT","volume":9266,"amount":3542.3422269000002,"timestamp":1789560306632,"change":-0.0082,"changeRate":-0.021069,"amplitude":0.021326},"delay":0,"changeRate":0.0015440041173442856,"floatShares":95966000,"shares":97986634,"eps":-0.621383,"marketStatus":"Pre-Mkt","change":0.0006,"latestTime":"09-16 08:15:59 EDT","open":0.394,"high":0.4008,"low":0.375,"amount":408974.69942868,"amplitude":0.066392,"askPrice":0.397,"askSize":500,"bidPrice":0.38,"bidSize":10,"shortable":3,"etf":0,"ttmEps":-0.621383,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1789565400000},"marketStatusCode":1,"adr":0,"listingDate":1430971200000,"exchange":"NASDAQ","adjPreClose":0.3892,"preHourTrading":{"tag":"盘前","latestPrice":0.381,"preClose":0.3892,"latestTime":"08:05 EDT","volume":9266,"amount":3542.3422269000002,"timestamp":1789560306632,"change":-0.0082,"changeRate":-0.021069,"amplitude":0.021326},"postHourTrading":{"tag":"盘后","latestPrice":0.3888,"preClose":0.3892,"latestTime":"19:53 EDT","volume":1783,"amount":697.4248,"timestamp":1789516429878,"change":-0.0004,"changeRate":-0.001028,"amplitude":0.020555},"volumeRatio":0.9558699798760506,"impliedVol":2.372,"impliedVolPercentile":0.792},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ATYR\",,,,,undefined,":{"symbol":"ATYR","floatShares":95966000,"roa":"-46.58%","roe":"-98.68%","lyrEps":-0.797093,"volumeRatio":0.9558699798760506,"shares":97986634,"dividePrice":0,"high":0.4008,"amplitude":0.066392,"preClose":0.3886,"low":0.375,"week52Low":0.375,"pbRate":"0.78","psRate":"200.72","week52High":1.2,"institutionHeld":0,"latestPrice":0.3892,"committee":-0.960784,"eps":-0.621383,"divideRate":0,"volume":1059982,"delay":0,"ttmEps":-0.621383,"open":0.394,"prevYearClose":0.7831,"prevWeekClose":0.4298,"prevMonthClose":0.5317,"prevQuarterClose":0.5968,"fiveDayClose":0.4808,"twentyDayClose":0.5189,"sixtyDayClose":0.4505},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ATYR\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-07","symbol":"ATYR","fiscalQuarterEnding":"2026/06","expectedEps":-0.15,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1786075200000,"reportTimeType":"post","actualEps":-0.11},{"market":"US","date":"2026-05-15","symbol":"ATYR","fiscalQuarterEnding":"2026/03","expectedEps":-0.16,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1778817600000,"reportTimeType":"pre","actualEps":-0.11},{"market":"US","date":"2026-03-05","symbol":"ATYR","fiscalQuarterEnding":"2025/12","expectedEps":-0.18,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1772686800000,"reportTimeType":"post","actualEps":-0.14},{"market":"US","date":"2025-11-06","symbol":"ATYR","fiscalQuarterEnding":"2025/09","expectedEps":-0.2,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1762405200000,"reportTimeType":"post","actualEps":-0.26},{"market":"US","date":"2025-08-07","symbol":"ATYR","fiscalQuarterEnding":"2025/06","expectedEps":-0.18,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1754539200000,"reportTimeType":"post","actualEps":-0.22}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ATYR\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ATYR\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1111,"buy":0.3333,"hold":0.5556,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.3333,"analysts":9,"updateTime":1779336000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ATYR\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ATYR","date":"2026-09-15","current":-0.626345,"percent":0.992714,"low":-9.277729,"twenty":-4.919528,"median":-2.317206,"eighty":-0.953831,"high":-0.523739,"avg":-3.04513,"sd":2.332374,"marketCap":38116773},"quantilePoints":[{"date":"2024-06-07","current":-2.380173,"twenty":-2.380173,"median":-2.380173,"eighty":-2.380173,"marketCap":128360348},{"date":"2024-06-14","current":-2.367376,"twenty":-2.482546,"median":-2.431359,"eighty":-2.377614,"marketCap":127670239},{"date":"2024-06-21","current":-2.021867,"twenty":-2.446715,"median":-2.367376,"eighty":-2.203579,"marketCap":109037285},{"date":"2024-06-28","current":-1.970681,"twenty":-2.431359,"median":-2.367376,"eighty":-2.111444,"marketCap":106276847},{"date":"2024-07-05","current":-1.970681,"twenty":-2.431359,"median":-2.265003,"eighty":-1.991155,"marketCap":106276847},{"date":"2024-07-12","current":-2.073054,"twenty":-2.39041,"median":-2.092249,"eighty":-1.970681,"marketCap":111797722},{"date":"2024-07-15","current":-2.226613,"twenty":-2.380173,"median":-2.111444,"eighty":-1.970681,"marketCap":120079035},{"date":"2024-08-02","current":-2.495343,"twenty":-2.421122,"median":-2.130639,"eighty":-1.9758,"marketCap":134571333},{"date":"2024-08-09","current":-2.380173,"twenty":-2.403207,"median":-2.265003,"eighty":-1.996274,"marketCap":128360348},{"date":"2024-08-16","current":-2.618312,"twenty":-2.418704,"median":-2.296995,"eighty":-2.001393,"marketCap":151592396},{"date":"2024-08-23","current":-2.448121,"twenty":-2.445503,"median":-2.341783,"eighty":-2.021867,"marketCap":141738890},{"date":"2024-08-30","current":-2.474305,"twenty":-2.468042,"median":-2.373775,"eighty":-2.032104,"marketCap":143254814},{"date":"2024-09-06","current":-2.291023,"twenty":-2.461213,"median":-2.354579,"eighty":-2.073054,"marketCap":132643346},{"date":"2024-09-13","current":-2.448121,"twenty":-2.474305,"median":-2.380173,"eighty":-2.111444,"marketCap":141738890},{"date":"2024-09-20","current":-2.448121,"twenty":-2.474305,"median":-2.399368,"eighty":-2.149834,"marketCap":141738890},{"date":"2024-09-27","current":-2.277931,"twenty":-2.474305,"median":-2.382664,"eighty":-2.226613,"marketCap":131885384},{"date":"2024-10-04","current":-2.277931,"twenty":-2.469749,"median":-2.373775,"eighty":-2.226613,"marketCap":131885384},{"date":"2024-10-11","current":-2.77541,"twenty":-2.474305,"median":-2.382664,"eighty":-2.251748,"marketCap":160687939},{"date":"2024-10-18","current":-3.469263,"twenty":-2.48085,"median":-2.399368,"eighty":-2.251748,"marketCap":200859924},{"date":"2024-10-25","current":-4.241665,"twenty":-2.500488,"median":-2.421938,"eighty":-2.265003,"marketCap":245579681},{"date":"2024-10-31","current":-4.097658,"twenty":-2.555472,"median":-2.431359,"eighty":-2.275241,"marketCap":237242099},{"date":"2024-11-08","current":-4.058383,"twenty":-2.922036,"median":-2.441575,"eighty":-2.277905,"marketCap":234968213},{"date":"2024-11-15","current":-3.78886,"twenty":-3.621287,"median":-2.448121,"eighty":-2.277931,"marketCap":241789871},{"date":"2024-11-22","current":-3.919838,"twenty":-3.629704,"median":-2.448121,"eighty":-2.277931,"marketCap":250148372},{"date":"2024-11-29","current":-4.643298,"twenty":-3.916561,"median":-2.461213,"eighty":-2.285786,"marketCap":296316696},{"date":"2024-12-06","current":-4.301299,"twenty":-4.007344,"median":-2.474305,"eighty":-2.298878,"marketCap":274491670},{"date":"2024-12-13","current":-3.972453,"twenty":-4.100191,"median":-2.474305,"eighty":-2.31136,"marketCap":253506069},{"date":"2024-12-20","current":-4.143453,"twenty":-4.111931,"median":-2.474305,"eighty":-2.3168,"marketCap":264418582},{"date":"2024-12-27","current":-4.95899,"twenty":-4.144489,"median":-2.487396,"eighty":-2.317206,"marketCap":316462874},{"date":"2025-01-03","current":-5.143143,"twenty":-4.229494,"median":-2.500488,"eighty":-2.317206,"marketCap":328214811},{"date":"2025-01-10","current":-4.919528,"twenty":-4.267848,"median":-2.526671,"eighty":-2.317206,"marketCap":313944602},{"date":"2025-01-17","current":-4.932682,"twenty":-4.327606,"median":-2.579037,"eighty":-2.328986,"marketCap":314784026},{"date":"2025-01-24","current":-4.682759,"twenty":-4.341161,"median":-2.768865,"eighty":-2.330035,"marketCap":298834968},{"date":"2025-01-31","current":-4.919528,"twenty":-4.389843,"median":-2.932509,"eighty":-2.330297,"marketCap":313944602},{"date":"2025-02-07","current":-5.090528,"twenty":-4.509129,"median":-3.510289,"eighty":-2.339486,"marketCap":324857115},{"date":"2025-02-14","current":-4.722221,"twenty":-4.606467,"median":-3.575068,"eighty":-2.341783,"marketCap":301353241},{"date":"2025-02-21","current":-5.827142,"twenty":-4.643298,"median":-3.6107,"eighty":-2.357139,"marketCap":371864863},{"date":"2025-02-28","current":-5.090528,"twenty":-4.682759,"median":-3.851618,"eighty":-2.375054,"marketCap":324857115},{"date":"2025-03-07","current":-4.051376,"twenty":-4.682759,"median":-3.972453,"eighty":-2.380173,"marketCap":258542613},{"date":"2025-03-14","current":-5.248373,"twenty":-4.682759,"median":-3.985607,"eighty":-2.381668,"marketCap":334930203},{"date":"2025-03-21","current":-4.929845,"twenty":-4.727483,"median":-3.990774,"eighty":-2.382664,"marketCap":315623450},{"date":"2025-03-28","current":-4.52461,"twenty":-4.75379,"median":-4.035211,"eighty":-2.388848,"marketCap":289679075},{"date":"2025-04-04","current":-3.872289,"twenty":-4.740636,"median":-4.038222,"eighty":-2.400648,"marketCap":247915527},{"date":"2025-04-11","current":-3.802893,"twenty":-4.727483,"median":-4.011134,"eighty":-2.407615,"marketCap":243472596},{"date":"2025-04-17","current":-4.191509,"twenty":-4.722221,"median":-4.035211,"eighty":-2.414083,"marketCap":268353008},{"date":"2025-04-25","current":-4.788314,"twenty":-4.743267,"median":-4.051376,"eighty":-2.421938,"marketCap":306562211},{"date":"2025-05-02","current":-4.635643,"twenty":-4.743267,"median":-4.087671,"eighty":-2.425706,"marketCap":296787764},{"date":"2025-05-09","current":-4.680309,"twenty":-4.75642,"median":-4.108234,"eighty":-2.431359,"marketCap":296787764},{"date":"2025-05-16","current":-4.210769,"twenty":-4.743267,"median":-4.133647,"eighty":-2.432827,"marketCap":267013308},{"date":"2025-05-23","current":-5.333641,"twenty":-4.774836,"median":-4.143453,"eighty":-2.440266,"marketCap":338216856},{"date":"2025-05-30","current":-5.972275,"twenty":-4.816072,"median":-4.149872,"eighty":-2.448121,"marketCap":378713875},{"date":"2025-06-06","current":-7.509205,"twenty":-4.87282,"median":-4.17922,"eighty":-2.448121,"marketCap":476173732},{"date":"2025-06-13","current":-7.621493,"twenty":-4.919528,"median":-4.191509,"eighty":-2.448121,"marketCap":483294087},{"date":"2025-06-20","current":-7.256559,"twenty":-4.932682,"median":-4.241665,"eighty":-2.448121,"marketCap":460152934},{"date":"2025-06-27","current":-7.453062,"twenty":-4.985297,"median":-4.254757,"eighty":-2.448121,"marketCap":472613555},{"date":"2025-07-03","current":-7.453062,"twenty":-5.016231,"median":-4.28094,"eighty":-2.448121,"marketCap":472613555},{"date":"2025-07-11","current":-7.481134,"twenty":-5.080005,"median":-4.302543,"eighty":-2.458595,"marketCap":474393643},{"date":"2025-07-18","current":-8.126785,"twenty":-5.119466,"median":-4.327606,"eighty":-2.461213,"marketCap":515335684},{"date":"2025-07-25","current":-7.796941,"twenty":-5.18655,"median":-4.339852,"eighty":-2.468042,"marketCap":494419641},{"date":"2025-08-01","current":-6.624944,"twenty":-5.237851,"median":-4.345289,"eighty":-2.473394,"marketCap":420100937},{"date":"2025-08-08","current":-7.354811,"twenty":-5.277498,"median":-4.380221,"eighty":-2.474305,"marketCap":466383244},{"date":"2025-08-15","current":-7.337565,"twenty":-5.711388,"median":-4.396173,"eighty":-2.474305,"marketCap":488953303},{"date":"2025-08-22","current":-7.278747,"twenty":-6.338611,"median":-4.472298,"eighty":-2.474305,"marketCap":485033838},{"date":"2025-08-29","current":-7.866928,"twenty":-6.868599,"median":-4.491152,"eighty":-2.474305,"marketCap":524228491},{"date":"2025-09-05","current":-8.043383,"twenty":-7.051635,"median":-4.498606,"eighty":-2.474305,"marketCap":535986887},{"date":"2025-09-12","current":-7.734587,"twenty":-7.202339,"median":-4.538489,"eighty":-2.478232,"marketCap":515409694},{"date":"2025-09-19","current":-1.543977,"twenty":-7.202339,"median":-4.511608,"eighty":-2.474305,"marketCap":102885965},{"date":"2025-09-26","current":-1.313556,"twenty":-7.183573,"median":-4.496851,"eighty":-2.466335,"marketCap":87531460},{"date":"2025-10-03","current":-1.043875,"twenty":-7.138658,"median":-4.477635,"eighty":-2.448121,"marketCap":69560711},{"date":"2025-10-10","current":-1.401343,"twenty":-7.082514,"median":-4.406529,"eighty":-2.442885,"marketCap":93381262},{"date":"2025-10-17","current":-1.470454,"twenty":-7.051635,"median":-4.382946,"eighty":-2.421938,"marketCap":97986634},{"date":"2025-10-24","current":-1.430458,"twenty":-7.012335,"median":-4.346398,"eighty":-2.388848,"marketCap":95321397},{"date":"2025-10-31","current":-1.305763,"twenty":-6.956191,"median":-4.340306,"eighty":-2.375054,"marketCap":87012130},{"date":"2025-11-07","current":-1.004754,"twenty":-6.884883,"median":-4.327606,"eighty":-2.330297,"marketCap":75479104},{"date":"2025-11-14","current":-0.930535,"twenty":-6.741157,"median":-4.315074,"eighty":-2.317206,"marketCap":69903664},{"date":"2025-11-21","current":-0.849664,"twenty":-6.641787,"median":-4.294031,"eighty":-2.285786,"marketCap":63828493},{"date":"2025-11-28","current":-1.018058,"twenty":-6.613715,"median":-4.254757,"eighty":-2.277852,"marketCap":76478567},{"date":"2025-12-05","current":-1.079755,"twenty":-6.467742,"median":-4.247271,"eighty":-2.236667,"marketCap":81113335},{"date":"2025-12-12","current":-0.998232,"twenty":-6.153338,"median":-4.191509,"eighty":-2.08841,"marketCap":74989171},{"date":"2025-12-19","current":-0.9171,"twenty":-5.941396,"median":-4.17922,"eighty":-1.996274,"marketCap":68894402},{"date":"2025-12-26","current":-0.962753,"twenty":-5.88149,"median":-4.159816,"eighty":-1.970681,"marketCap":72323934},{"date":"2026-01-02","current":-1.02145,"twenty":-5.827142,"median":-4.144316,"eighty":-1.58809,"marketCap":76733333},{"date":"2026-01-09","current":-0.945796,"twenty":-5.68245,"median":-4.143453,"eighty":-1.529272,"marketCap":71050108},{"date":"2026-01-16","current":-0.921535,"twenty":-5.590373,"median":-4.115174,"eighty":-1.499863,"marketCap":69227556},{"date":"2026-01-23","current":-0.973579,"twenty":-5.463588,"median":-4.100824,"eighty":-1.470454,"marketCap":73137223},{"date":"2026-01-30","current":-1.109494,"twenty":-5.353291,"median":-4.058383,"eighty":-1.430928,"marketCap":83347430},{"date":"2026-02-06","current":-1.05745,"twenty":-5.277498,"median":-4.044799,"eighty":-1.420105,"marketCap":79437764},{"date":"2026-02-13","current":-1.16206,"twenty":-5.263462,"median":-4.025068,"eighty":-1.381433,"marketCap":87296292},{"date":"2026-02-20","current":-1.369585,"twenty":-5.259961,"median":-3.990774,"eighty":-1.302178,"marketCap":102885965},{"date":"2026-02-27","current":-1.291323,"twenty":-5.252075,"median":-3.985607,"eighty":-1.296092,"marketCap":97006767},{"date":"2026-03-06","current":-1.193659,"twenty":-5.240481,"median":-3.979834,"eighty":-1.286732,"marketCap":88471608},{"date":"2026-03-13","current":-1.147622,"twenty":-5.227328,"median":-3.937701,"eighty":-1.255818,"marketCap":85059426},{"date":"2026-03-20","current":-1.094838,"twenty":-5.211936,"median":-3.872289,"eighty":-1.237152,"marketCap":81147183},{"date":"2026-03-27","current":-1.048668,"twenty":-5.203474,"median":-3.781997,"eighty":-1.214301,"marketCap":77725195},{"date":"2026-04-02","current":-1.125529,"twenty":-5.194443,"median":-3.671031,"eighty":-1.194857,"marketCap":83421971},{"date":"2026-04-10","current":-0.99218,"twenty":-5.16682,"median":-3.600179,"eighty":-1.172887,"marketCap":73538409},{"date":"2026-04-17","current":-1.098674,"twenty":-5.140003,"median":-3.556109,"eighty":-1.163625,"marketCap":81431531},{"date":"2026-04-24","current":-1.047345,"twenty":-5.133171,"median":-3.450357,"eighty":-1.14771,"marketCap":77627144},{"date":"2026-05-01","current":-1.068115,"twenty":-5.124727,"median":-2.847414,"eighty":-1.126799,"marketCap":79166548},{"date":"2026-05-08","current":-1.219456,"twenty":-5.106312,"median":-2.618312,"eighty":-1.12201,"marketCap":90383607},{"date":"2026-05-15","current":-0.740696,"twenty":-5.090528,"median":-2.530202,"eighty":-1.115819,"marketCap":54898873},{"date":"2026-05-22","current":-0.73998,"twenty":-5.090528,"median":-2.500488,"eighty":-1.110669,"marketCap":51820065},{"date":"2026-05-29","current":-0.682434,"twenty":-5.087897,"median":-2.487396,"eighty":-1.099177,"marketCap":47790160},{"date":"2026-06-05","current":-0.718278,"twenty":-5.076713,"median":-2.474305,"eighty":-1.090075,"marketCap":50300271},{"date":"2026-06-12","current":-0.665632,"twenty":-5.066838,"median":-2.474305,"eighty":-1.075368,"marketCap":46613546},{"date":"2026-06-18","current":-0.64813,"twenty":-5.037912,"median":-2.474305,"eighty":-1.068115,"marketCap":45387906},{"date":"2026-06-26","current":-0.783665,"twenty":-5.034735,"median":-2.461213,"eighty":-1.059407,"marketCap":54879263},{"date":"2026-07-02","current":-0.825809,"twenty":-5.016231,"median":-2.448121,"eighty":-1.056783,"marketCap":57830604},{"date":"2026-07-10","current":-0.814468,"twenty":-4.999522,"median":-2.448121,"eighty":-1.048403,"marketCap":57036390},{"date":"2026-07-17","current":-0.722338,"twenty":-4.987538,"median":-2.441575,"eighty":-1.042823,"marketCap":50584620},{"date":"2026-07-24","current":-0.697415,"twenty":-4.985297,"median":-2.431359,"eighty":-1.025832,"marketCap":48839308},{"date":"2026-07-31","current":-0.672073,"twenty":-4.975365,"median":-2.421938,"eighty":-1.016915,"marketCap":47064581},{"date":"2026-08-07","current":-0.702876,"twenty":-4.962891,"median":-2.399368,"eighty":-1.009084,"marketCap":49221708},{"date":"2026-08-14","current":-0.892041,"twenty":-4.95899,"median":-2.382664,"eighty":-0.99687,"marketCap":54242346},{"date":"2026-08-21","current":-0.811386,"twenty":-4.943205,"median":-2.373775,"eighty":-0.980779,"marketCap":49337974},{"date":"2026-08-28","current":-0.894622,"twenty":-4.93098,"median":-2.341783,"eighty":-0.973371,"marketCap":54399285},{"date":"2026-09-04","current":-0.812193,"twenty":-4.923655,"median":-2.329642,"eighty":-0.966814,"marketCap":49387018},{"date":"2026-09-11","current":-0.696695,"twenty":-4.919528,"median":-2.317206,"eighty":-0.959075,"marketCap":42363958},{"date":"2026-09-15","current":-0.626848,"twenty":-4.919528,"median":-2.317206,"eighty":-0.953831,"marketCap":38116773}],"updateTime":1789560959556},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"ATYR\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2666571406","title":"aTyr Pharma Announces Special Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2666571406","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2666571406?lang=en_us&edition=fundamental","pubTime":"2026-09-12 04:07","pubTimestamp":1789157246,"startTime":"0","endTime":"0","summary":"aTyr Pharma announces special shareholder meetingaTyr Pharma will hold a special stockholder meeting in San Diego, California on Oct. 16, 2026.Shareholders will vote on authorizing the board to implement a reverse stock split at a ratio from 1-for-10 to 1-for-50.Disclaimer:This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. aTyr Pharma Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on September 11, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260911:nNDL8Dd5QH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATYR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664691678","title":"aTyr Pharma Expects FDA Response by Mid-September on Efzofitimod Phase 3 Sarcoidosis Protocol","url":"https://stock-news.laohu8.com/highlight/detail?id=2664691678","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664691678?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:36","pubTimestamp":1788294988,"startTime":"0","endTime":"0","summary":"aTyr Pharma expects FDA response by mid-September on efzofitimod Phase 3 sarcoidosis protocolaTyr Pharma expects an FDA response by mid-September on its June protocol submission for a planned Phase 3 ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nNDL8dv7gk:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","BK4139","LU2210149790.SGD","IE00BKPKM429.USD","LU2210150020.SGD","LU2095319765.USD","IE00BQXX3D17.EUR","BK4588","IE00BQXX3C00.GBP","SG9999014039.USD","SG9999014021.USD","IE00BN0W2V16.EUR","IE00BQXX3F31.USD","ATYR","NDAQ","LU0314104364.USD","IE00BN0W2T93.GBP","BK4112","BCDF","SG9999014013.SGD","BK4585","IE00BN0W2W23.USD","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","SG9999014005.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664286997","title":"aTyr Pharma Provides Update on Timing of Regulatory Response for Planned Phase 3 Study of Efzofitimod in Pulmonary Sarcoidosis","url":"https://stock-news.laohu8.com/highlight/detail?id=2664286997","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664286997?lang=en_us&edition=fundamental","pubTime":"2026-09-02 04:36","pubTimestamp":1788294969,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260901:nTUA8PMY6F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ATYR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663077886","title":"aTyr Pharma Announces Special Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2663077886","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2663077886?lang=en_us&edition=fundamental","pubTime":"2026-08-31 19:01","pubTimestamp":1788174076,"startTime":"0","endTime":"0","summary":"aTyr Pharma announces special shareholder meetingaTyr Pharma schedules a special shareholder meeting in San Diego on Oct. 16, 2026.Vote sought to authorize a reverse stock split, with the ratio set by","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260831:nNDLY73Zz:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATYR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658193426","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: Embecta Corporation (EMBC) and aTyr Pharma (ATYR)","url":"https://stock-news.laohu8.com/highlight/detail?id=2658193426","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2658193426?lang=en_us&edition=fundamental","pubTime":"2026-08-10 22:01","pubTimestamp":1786370462,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Embecta Corporation (EMBC) and aTyr Pharma (ATYR)....","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-embecta-corporation-embc-and-atyr-pharma-atyr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-embecta-corporation-embc-and-atyr-pharma-atyr-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4137","BK4139","EMBC","XBI","LABU","LU0029874061.USD","ATYR","HCSG","BK4581","BK4198","LU0128526141.USD","BK4588","BK4585","XLV"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657626404","title":"ATyr Pharma to Cut 60% of Staff, Bring in New CFO in Restructuring Push","url":"https://stock-news.laohu8.com/highlight/detail?id=2657626404","media":"Dow Jones","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657626404?lang=en_us&edition=fundamental","pubTime":"2026-08-08 04:31","pubTimestamp":1786134660,"startTime":"0","endTime":"0","summary":"ATyr Pharma appointed a new finance chief and said it would lay off around 60% of its staff in an effort to conserve capital and prioritize the development of efzofitimod, its interstitial lung diseas","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"ATyr Pharma to Cut 60% of Staff, Bring in New CFO in Restructuring Push","news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATYR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657266426","title":"aTyr Pharma Inc Reports Results for the Quarter Ended June 30 - Earnings Summary","url":"https://stock-news.laohu8.com/highlight/detail?id=2657266426","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657266426?lang=en_us&edition=fundamental","pubTime":"2026-08-08 04:20","pubTimestamp":1786134041,"startTime":"0","endTime":"0","summary":"aTyr Pharma Inc reports results for the quarter ended June 30 - Earnings SummaryaTyr Pharma IncATYR.OQreported a quarterly adjusted loss of 11 cents per share for the quarter ended June 30, higher tha","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL8N4442HF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ATYR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657062657","title":"aTyr Pharma Q2 Net Loss Narrows","url":"https://stock-news.laohu8.com/highlight/detail?id=2657062657","media":"Reuters","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657062657?lang=en_us&edition=fundamental","pubTime":"2026-08-08 04:17","pubTimestamp":1786133859,"startTime":"0","endTime":"0","summary":"aTyr Pharma Q2 net loss narrowsOverviewUS biotech firm posted Q2 net loss of $10.3 mln vs loss of $19.5 mln year agoCompany announced 60% workforce reduction to focus on efzofitimod in ILDEnded Q2 202","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nL1N4440Y7:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["EBS","BK4139","IMRX","BK4563","BK4532","LU1699723380.USD","UTHR","LU1571399168.USD","ATYR","BK4583","BK4539"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657800626","title":"aTyr Pharma Submits Phase 3 Efzofitimod Trial Protocol to FDA for Pulmonary Sarcoidosis Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2657800626","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657800626?lang=en_us&edition=fundamental","pubTime":"2026-08-08 04:08","pubTimestamp":1786133294,"startTime":"0","endTime":"0","summary":"aTyr Pharma submits Phase 3 efzofitimod trial protocol to FDA for pulmonary sarcoidosis studyaTyr Pharma completed enrollment in its Phase 2 EFZO-CONNECT study of efzofitimod in SSc-ILD; topline resul","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nNDL7HzPMm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATYR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657625069","title":"aTyr Pharma Q2 EPS $(0.11) Beats $(0.12) Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2657625069","media":"Benzinga Earnings","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657625069?lang=en_us&edition=fundamental","pubTime":"2026-08-08 04:02","pubTimestamp":1786132931,"startTime":"0","endTime":"0","summary":"aTyr Pharma (NASDAQ:ATYR) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.12) by 8.33 percent. This is a 50 percent increase over losses of $(0.22) per share from the same","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/08/61055869/atyr-pharma-q2-eps-0-11-beats-0-12-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"aTyr Pharma Q2 EPS $(0.11) Beats $(0.12) Estimate","news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATYR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657756625","title":"aTyr Pharma - Expects $13 Mln Reduction in Annualized Operating Expenses Beginning Q4 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2657756625","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657756625?lang=en_us&edition=fundamental","pubTime":"2026-08-08 04:01","pubTimestamp":1786132860,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nTUA7ZRM8M:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ATYR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657625758","title":"aTyr Pharma - Announces Workforce Reduction of About 60% to Focus on Efzofitimod Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2657625758","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657625758?lang=en_us&edition=fundamental","pubTime":"2026-08-08 04:01","pubTimestamp":1786132860,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nTUA7ZRM8M:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ATYR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657625754","title":"aTyr Pharma - Jill Broadfoot to Step Down as CFO; Brandon Yaras Appointed CFO Effective October 1, 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2657625754","media":"THOMSON REUTERS","labels":["executive","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657625754?lang=en_us&edition=fundamental","pubTime":"2026-08-08 04:01","pubTimestamp":1786132860,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260807:nTUA7ZRM8M:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,event","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ATYR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657625012","title":"Press Release: aTyr Pharma Announces Second Quarter 2026 Results, Program Prioritization and Corporate Restructuring to Support Efzofitimod Program in ILD","url":"https://stock-news.laohu8.com/highlight/detail?id=2657625012","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657625012?lang=en_us&edition=fundamental","pubTime":"2026-08-08 04:01","pubTimestamp":1786132860,"startTime":"0","endTime":"0","summary":"resources to support the efzofitimod program in ILD in anticipation of. comments from the FDA on a protocol submitted for a planned Phase 3 study. in pulmonary sarcoidosis and to complete the Phase 2 EFZO-CONNECT. -- Jill Broadfoot, aTyr's Chief Financial Officer , will step down as. of September 30, 2026, and transition to serve as a consultant t","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4585","BK4588","ATYR","CFO","BK4555","BK4099","LABU","03160","FVC","BK4604","BK4139","TM"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656304816","title":"Ethos Technologies Q2 Revenue Rises 113% on Policy Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2656304816","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656304816?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:19","pubTimestamp":1785788389,"startTime":"0","endTime":"0","summary":"Ethos Technologies Q2 revenue rises 113% on policy growthOverviewUS life insurance tech firm's Q2 revenue grew 113% yr/yr to $190 mlnNet income for Q2 was $19.5 mln; adjusted EBITDA margin reached 19%","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL1N440106:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4173","BK4563","ATYR","BK4139","LIFE"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656820301","title":"aTyr Pharma Q2 Net Income USD 19.531 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2656820301","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656820301?lang=en_us&edition=fundamental","pubTime":"2026-08-04 04:05","pubTimestamp":1785787503,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nPLX68GRR2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ATYR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656375707","title":"aTyr Pharma Inc Expected to Post a Loss of 12 Cents a Share - Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2656375707","media":"Reuters","labels":["dataReport","preview"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656375707?lang=en_us&edition=fundamental","pubTime":"2026-08-03 19:44","pubTimestamp":1785757459,"startTime":"0","endTime":"0","summary":"aTyr Pharma Inc <ATYR.OQ> expected to post a loss of12cents a share - Earnings PreviewaTyr Pharma IncATYR.OQATYR.Ois expected to  show no change in quarterly revenue when it reports  results on August","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260803:nL8N440124:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,preview","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","ATYR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656666391","title":"aTyr Pharma - Co and Kyorin Terminate Collaboration Agreement Effective July 30, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2656666391","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656666391?lang=en_us&edition=fundamental","pubTime":"2026-08-01 04:48","pubTimestamp":1785530883,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nFWN43X2NR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["ATYR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2656391665","title":"aTyr Pharma - Regains Exclusive Global Rights to Efzofitimod - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2656391665","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2656391665?lang=en_us&edition=fundamental","pubTime":"2026-08-01 04:48","pubTimestamp":1785530883,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260731:nFWN43X2NR:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","ATYR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655882330","title":"aTyr Pharma Lawsuit: Company Asks Court to Dismiss Investor Securities Claims","url":"https://stock-news.laohu8.com/highlight/detail?id=2655882330","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655882330?lang=en_us&edition=fundamental","pubTime":"2026-07-29 02:56","pubTimestamp":1785265000,"startTime":"0","endTime":"0","summary":"aTyr Pharma (ATYR) and two executives have asked a federal court to dismiss an amended investor lawsuit over statements tied to the company’s efzof...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/class-action/atyr-pharma-lawsuit-company-asks-court-to-dismiss-investor-securities-claims?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/class-action/atyr-pharma-lawsuit-company-asks-court-to-dismiss-investor-securities-claims?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ATYR","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":3,"pageCount":1,"totalSize":49,"code":"91000000","status":"200"}]}}